About Ascribe Bioscience
Ascribe Bioscience is a company based in Ithaca (United States) founded in 2017 by Murli Manohar.. Ascribe Bioscience has raised $17.68 million across 9 funding rounds from investors including Corteva Agriscience, HHS and The Yield Lab. Ascribe Bioscience offers products and services including Phytalix. Ascribe Bioscience operates in a competitive market with competitors including Ginkgo Bioworks, AgBiome, Pluton Biosciences, AgroSpheres and Boost Biomes, among others.
- Headquarter Ithaca, United States
- Founders Murli Manohar
-
Sectors
Chemicals & MaterialsAgriculture
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ascribe Bioscience Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.68 M (USD)
in 9 rounds
-
Latest Funding Round
$12 M (USD), Series A
Oct 14, 2025
-
Investors
Corteva Agriscience
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ascribe Bioscience
Ascribe Bioscience offers a comprehensive portfolio of products and services, including Phytalix. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Natural product that protects crops from fungal and bacterial pathogens using soil molecules.
Unlock access to complete
Unlock access to complete
Funding Insights of Ascribe Bioscience
Ascribe Bioscience has successfully raised a total of $17.68M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series A — $12.0M
-
First Round
First Round
(01 Feb 2019)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series A - Ascribe Bioscience | Valuation | Corteva Agriscience | |
| Feb, 2025 | Amount | Series A - Ascribe Bioscience | Valuation |
investors |
|
| Nov, 2024 | Amount | Series A - Ascribe Bioscience | Valuation | Source Agriculture |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ascribe Bioscience
Ascribe Bioscience has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Corteva Agriscience, HHS and The Yield Lab. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A privately owned industrial group focused on chemical investments.
|
Founded Year | Domain | Location | |
|
Venture capital firm & accelerator focused on early-stage companies
|
Founded Year | Domain | Location | |
|
Early & late stage life sciences & tech focused VC firm investing primarily in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ascribe Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ascribe Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ascribe Bioscience Comparisons
Competitors of Ascribe Bioscience
Ascribe Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ginkgo Bioworks, AgBiome, Pluton Biosciences, AgroSpheres and Boost Biomes, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Provider of microbe-based crop protection solutions
|
|
| domain | founded_year | HQ Location |
Assay-based microbial research services are offered for industrial applications.
|
|
| domain | founded_year | HQ Location |
Manufacturer and supplier of biological agrochemicals
|
|
| domain | founded_year | HQ Location |
Microbiome-based products for crop protection are developed using DNA sequencing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ascribe Bioscience
Frequently Asked Questions about Ascribe Bioscience
When was Ascribe Bioscience founded?
Ascribe Bioscience was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Ascribe Bioscience located?
Ascribe Bioscience is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Is Ascribe Bioscience a funded company?
Ascribe Bioscience is a funded company, having raised a total of $17.68M across 9 funding rounds to date.
What does Ascribe Bioscience do?
Ascribe Bioscience was founded in 2017 in Ithaca, United States, within the agricultural biotechnology sector. Microbe-based biological inputs for crops are developed, focusing on natural biopesticides. Plant immunity is enhanced, and pathogens such as fungi, bacteria, nematodes, and viruses are targeted across various crops. Applications include seed treatments, foliar sprays, and soil additives to support crop protection operations.
Who are the top competitors of Ascribe Bioscience?
Ascribe Bioscience's top competitors include Ginkgo Bioworks, AgroSpheres and Switch Bioworks.
What products or services does Ascribe Bioscience offer?
Ascribe Bioscience offers Phytalix.
Who are Ascribe Bioscience's investors?
Ascribe Bioscience has 10 investors. Key investors include Corteva Agriscience, HHS, The Yield Lab, International Chemical Investors, and Source Agriculture.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.